Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorization (EUA) of its single-dose vaccine against novel Coronavirus in India. The company, in a statement, said that it will bring the vaccine through a collaboration with Hyderabad-based Biological E. Limited.

“Biological E will be an important part of our global supply chain network, helping to supply our Covid-19 vaccine through the extensive collaborations and partnerships we have with governments, health authorities and organisations such as Gavi and the COVAX Facility,” it added.